Advances in Cancer Therapy

Kalorama Information
February 1, 2001
394 Pages - SKU: KLI25
The Market for Personalized Gene Therapy Treatments for Cancer
12/23/2014 | published by: Kalorama Information
The Market for Personalized Gene Therapy Treatments for Cancer This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for relatively new approach  |  read more...
USD 3,995
Global Cancer Biomarkers Market 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
Global Cancer Biomarkers Market 2015-2019 About Cancer Biomarkers Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly  |  read more...
USD 2,500
Fierce 15 in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
The prestigious Fierce 15 biotech award has come to symbolize novelty and being at the forefront of biotechnology development amongst privately held businesses. The winners of this award are aiming at breakthroughs and big things,  |  read more...
USD 4,478
Gene Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
There are today 122 companies plus partners developing 100 gene therapy drugs in 280 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last  |  read more...
USD 6,746
TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that play various roles in a broad spectrum of biological procedures. TSLP can be secreted by epithelial cells upon pathogen stimulation. TSLP can also activate dendritic cells,  |  read more...
USD 6,746
Hematological Cancers Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Unmet needs across the hematological malignancies remain high, with most traditional therapies conferring low levels of specificity and high toxicity. There are today 485 companies plus partners developing 752 hematological cancer drugs in 1767 developmental projects  |  read more...
USD 8,996
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. The hypoxia-inducible factors (HIFs) are a  |  read more...
USD 6,746
ID Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding capacity. This family  |  read more...
USD 2,246
Biotechnology (Nordic) - Industry Report
1/5/2015 | published by: Plimsoll Publishing Ltd.
Plimsoll’s Biotechnology (Nordic) analysis is the most definitive and accurate study of the Biotechnology (Nordic) sector in 2014. The report is split into two sections and uses both a written and graphical analysis – analysing the  |  read more...
USD 1,000
Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2015 Fore Pharma announced the results of its Acute Myeloid Leukemia patient population study in a new report ‘Global Acute Myeloid Leukemia Epidemiology and Patient Flow  |  read more...
USD 1,200
 

SELECT A LICENSE

    Online Download  USD 350  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!